Allen P. Grunes

Mr. Grunes is an antitrust lawyer in Brownstein’s DC office who advises clients on mergers and acquisitions and represents clients before the federal and state antitrust agencies and Congress.  He has experience in a range of industries including media and entertainment, telecommunications, healthcare, and the high-tech sector.  He previously spent more than a decade at the USDOJ Antitrust Division.

Mr. Grunes is co-author of Big Data and Competition Policy (Oxford University Press).  He currently serves on the Advisory Boards of the American Antitrust Institute and the Institute for Consumer Antitrust Studies at Loyola University Chicago School of Law.  He holds a bachelor’s degree from Dartmouth College, a law degree from Rutgers University, and a master of laws degree from New York University.

How Counterfeit Drugs Threaten U.S. Health and Innovation

By Anne Pritchett According to the Department of Homeland Security, counterfeit drugs “threaten national security and public safety directly when introduced into government and critical infrastructure supply chains, and indirectly if used to generate revenue for transnational criminal organizations.” Furthermore, counterfeit drugs harm pharmaceutical innovation by eroding profitability and investor
Read More

U.S. Universities: Engines of Economic Growth

By Sujai Shivakumar, Charles Wessner, Chris Borges, and Shruti Sharma Universities are among the United States’ most enduring sources of competitive advantage and a key pillar of the nation’s innovation system. Home to more than 35 of the world’s top 100 research universities, the United States owes many of its most
Read More

Andrei Iancu – Congressional Testimony: Hearing on the Patent Eligibility Restoration Act (PERA)

On October 8th, 2025, Andrei Iancu testified before the Senate Judiciary Committee, Subcommittee on Intellectual Property during the Hearing on the Patent Eligibility Restoration Act (PERA). Iancu, Partner at Sullivan & Cromwell, former Under Secretary of Commerce for IP and Director of the U.S. Patent and Trademark Office (USPTO), and
Read More